|
1
|
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
|
Gastroenterology
|
2007
|
2.96
|
|
2
|
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.
|
Inflamm Bowel Dis
|
2010
|
1.42
|
|
3
|
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response.
|
Gastroenterology
|
2010
|
1.32
|
|
4
|
Appraisal of the pediatric ulcerative colitis activity index (PUCAI).
|
Inflamm Bowel Dis
|
2009
|
1.18
|
|
5
|
Budesonide for induction of remission in Crohn's disease.
|
Cochrane Database Syst Rev
|
2008
|
1.14
|
|
6
|
A review of activity indices and end points for clinical trials in children with Crohn's disease.
|
Inflamm Bowel Dis
|
2005
|
1.13
|
|
7
|
Factors that determine risk for surgery in pediatric patients with Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2010
|
1.00
|
|
8
|
Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
|
Inflamm Bowel Dis
|
2015
|
0.99
|
|
9
|
Assessing disease activity in ulcerative colitis: patients or their physicians?
|
Inflamm Bowel Dis
|
2010
|
0.94
|
|
10
|
Budesonide for maintenance of remission in Crohn's disease.
|
Cochrane Database Syst Rev
|
2009
|
0.93
|
|
11
|
Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.
|
PLoS One
|
2010
|
0.91
|
|
12
|
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study.
|
Clin Gastroenterol Hepatol
|
2008
|
0.90
|
|
13
|
Experiences and barriers to Health-Related Quality of Life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents.
|
Health Qual Life Outcomes
|
2010
|
0.87
|
|
14
|
Budesonide for maintenance of remission in Crohn's disease.
|
Cochrane Database Syst Rev
|
2014
|
0.87
|
|
15
|
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.
|
J Pediatr Gastroenterol Nutr
|
2010
|
0.86
|
|
16
|
Understanding quality of life for children after liver transplantation: a work in progress.
|
Liver Transpl
|
2008
|
0.86
|
|
17
|
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
|
J Crohns Colitis
|
2013
|
0.84
|
|
18
|
Budesonide for induction of remission in Crohn's disease.
|
Cochrane Database Syst Rev
|
2015
|
0.84
|
|
19
|
Exclusive enteral nutrition for children with Crohn's disease: use in Australia and attitudes of Australian paediatric gastroenterologists.
|
J Paediatr Child Health
|
2009
|
0.84
|
|
20
|
Do parents and children agree? Quality-of-life assessment of children with inflammatory bowel disease and their parents.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.82
|
|
21
|
Budesonide for Crohn's disease.
|
Expert Opin Drug Metab Toxicol
|
2009
|
0.79
|
|
22
|
Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach.
|
J Clin Epidemiol
|
2009
|
0.78
|
|
23
|
Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
|
Inflamm Bowel Dis
|
2014
|
0.77
|
|
24
|
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: A workshop to identify barriers and enablers.
|
Can J Gastroenterol Hepatol
|
2015
|
0.76
|
|
25
|
Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.
|
J Pediatr Gastroenterol Nutr
|
2014
|
0.76
|
|
26
|
Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease.
|
Inflamm Bowel Dis
|
2016
|
0.76
|
|
27
|
The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.
|
Inflamm Bowel Dis
|
2016
|
0.76
|
|
28
|
The complement system in inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2014
|
0.75
|
|
29
|
Neutrophil transintestinal epithelial migration to CXCR2 ligands is regulated by adenosine.
|
J Pediatr Gastroenterol Nutr
|
2012
|
0.75
|
|
30
|
Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.
|
Can J Gastroenterol Hepatol
|
2014
|
0.75
|
|
31
|
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
|
Am J Gastroenterol
|
2017
|
0.75
|
|
32
|
Use of LARA-urea breath test in the diagnosis of Helicobacter pylori infection in children and adolescents: a preliminary study.
|
Can J Gastroenterol
|
2003
|
0.75
|
|
33
|
Generalisability of the inflammatory bowel disease knowledge inventory device to assess disease-related knowledge in Australian children.
|
J Paediatr Child Health
|
2014
|
0.75
|
|
34
|
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.
|
Cell Host Microbe
|
2017
|
0.75
|